Benjamin J. Zeskind, PRESIDENT AND CEO at Immuneering Corp (IMRX), bought 20,000 shares at $2.77 ($55K) on 2024-03-19, disclosed to the SEC on 2024-03-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| IMRX | BUY | 2025-06-20 | $50K | — | Filing → |
| IMRX | BUY | 2022-03-24 | $24K | — | Filing → |
| IMRX | BUY | 2021-09-14 | $48K | — | Filing → |